Global Taq DNA Polymerase 麻豆原创 Growth 2025-2031

Publication ID:

LPI06251449

Publication Date:

June 27, 2025

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Taq DNA Polymerase market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Taq DNA polymerase is a DNA polymerase widely used in PCR (polymerase chain reaction). It is named after it was originally isolated and purified from thermophilic bacteria (Thermus aquaticus). This enzyme is favored for its stability at high temperatures, allowing it to continuously work and exert polymerase activity in PCR reactions.
United States market for Taq DNA Polymerase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Taq DNA Polymerase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Taq DNA Polymerase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Taq DNA Polymerase players cover Thermo Fisher Scientific, QIAGEN, Takara, BioRad, New England Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淭aq DNA Polymerase Industry Forecast鈥� looks at past sales and reviews total world Taq DNA Polymerase sales in 2024, providing a comprehensive analysis by region and market sector of projected Taq DNA Polymerase sales for 2025 through 2031. With Taq DNA Polymerase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taq DNA Polymerase industry.
This Insight Report provides a comprehensive analysis of the global Taq DNA Polymerase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taq DNA Polymerase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Taq DNA Polymerase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taq DNA Polymerase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taq DNA Polymerase.
This report presents a comprehensive overview, market shares, and growth opportunities of Taq DNA Polymerase market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wild Type
Recombinant Type
Segmentation by Application:
Genetic Research
Medical Diagnosis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
QIAGEN
Takara
BioRad
New England Biolabs
Roche
Promega Corporation
Agilent
Vazyme
TransGen Biotech
Yeasen
Abclonal
CWbio
Novoprotein
Key Questions Addressed in this Report
What is the 10-year outlook for the global Taq DNA Polymerase market?
What factors are driving Taq DNA Polymerase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Taq DNA Polymerase market opportunities vary by end market size?
How does Taq DNA Polymerase break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Taq DNA Polymerase Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Taq DNA Polymerase by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Taq DNA Polymerase by Country/Region, 2020, 2024 & 2031
2.2 Taq DNA Polymerase Segment by Type
2.2.1 Wild Type
2.2.2 Recombinant Type
2.3 Taq DNA Polymerase Sales by Type
2.3.1 Global Taq DNA Polymerase Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Taq DNA Polymerase Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Taq DNA Polymerase Sale Price by Type (2020-2025)
2.4 Taq DNA Polymerase Segment by Application
2.4.1 Genetic Research
2.4.2 Medical Diagnosis
2.4.3 Other
2.5 Taq DNA Polymerase Sales by Application
2.5.1 Global Taq DNA Polymerase Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Taq DNA Polymerase Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Taq DNA Polymerase Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Taq DNA Polymerase Breakdown Data by Company
3.1.1 Global Taq DNA Polymerase Annual Sales by Company (2020-2025)
3.1.2 Global Taq DNA Polymerase Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Taq DNA Polymerase Annual Revenue by Company (2020-2025)
3.2.1 Global Taq DNA Polymerase Revenue by Company (2020-2025)
3.2.2 Global Taq DNA Polymerase Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Taq DNA Polymerase Sale Price by Company
3.4 Key Manufacturers Taq DNA Polymerase Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Taq DNA Polymerase Product Location Distribution
3.4.2 Players Taq DNA Polymerase Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Taq DNA Polymerase by Geographic Region
4.1 World Historic Taq DNA Polymerase 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Taq DNA Polymerase Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Taq DNA Polymerase Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Taq DNA Polymerase 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Taq DNA Polymerase Annual Sales by Country/Region (2020-2025)
4.2.2 Global Taq DNA Polymerase Annual Revenue by Country/Region (2020-2025)
4.3 Americas Taq DNA Polymerase Sales Growth
4.4 APAC Taq DNA Polymerase Sales Growth
4.5 Europe Taq DNA Polymerase Sales Growth
4.6 Middle East & Africa Taq DNA Polymerase Sales Growth
5 Americas
5.1 Americas Taq DNA Polymerase Sales by Country
5.1.1 Americas Taq DNA Polymerase Sales by Country (2020-2025)
5.1.2 Americas Taq DNA Polymerase Revenue by Country (2020-2025)
5.2 Americas Taq DNA Polymerase Sales by Type (2020-2025)
5.3 Americas Taq DNA Polymerase Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Taq DNA Polymerase Sales by Region
6.1.1 APAC Taq DNA Polymerase Sales by Region (2020-2025)
6.1.2 APAC Taq DNA Polymerase Revenue by Region (2020-2025)
6.2 APAC Taq DNA Polymerase Sales by Type (2020-2025)
6.3 APAC Taq DNA Polymerase Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Taq DNA Polymerase by Country
7.1.1 Europe Taq DNA Polymerase Sales by Country (2020-2025)
7.1.2 Europe Taq DNA Polymerase Revenue by Country (2020-2025)
7.2 Europe Taq DNA Polymerase Sales by Type (2020-2025)
7.3 Europe Taq DNA Polymerase Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Taq DNA Polymerase by Country
8.1.1 Middle East & Africa Taq DNA Polymerase Sales by Country (2020-2025)
8.1.2 Middle East & Africa Taq DNA Polymerase Revenue by Country (2020-2025)
8.2 Middle East & Africa Taq DNA Polymerase Sales by Type (2020-2025)
8.3 Middle East & Africa Taq DNA Polymerase Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Taq DNA Polymerase
10.3 Manufacturing Process Analysis of Taq DNA Polymerase
10.4 Industry Chain Structure of Taq DNA Polymerase
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Taq DNA Polymerase Distributors
11.3 Taq DNA Polymerase Customer
12 World Forecast Review for Taq DNA Polymerase by Geographic Region
12.1 Global Taq DNA Polymerase 麻豆原创 Size Forecast by Region
12.1.1 Global Taq DNA Polymerase Forecast by Region (2026-2031)
12.1.2 Global Taq DNA Polymerase Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Taq DNA Polymerase Forecast by Type (2026-2031)
12.7 Global Taq DNA Polymerase Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Taq DNA Polymerase Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 QIAGEN
13.2.1 QIAGEN Company Information
13.2.2 QIAGEN Taq DNA Polymerase Product Portfolios and Specifications
13.2.3 QIAGEN Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 QIAGEN Main Business Overview
13.2.5 QIAGEN Latest Developments
13.3 Takara
13.3.1 Takara Company Information
13.3.2 Takara Taq DNA Polymerase Product Portfolios and Specifications
13.3.3 Takara Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Takara Main Business Overview
13.3.5 Takara Latest Developments
13.4 BioRad
13.4.1 BioRad Company Information
13.4.2 BioRad Taq DNA Polymerase Product Portfolios and Specifications
13.4.3 BioRad Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BioRad Main Business Overview
13.4.5 BioRad Latest Developments
13.5 New England Biolabs
13.5.1 New England Biolabs Company Information
13.5.2 New England Biolabs Taq DNA Polymerase Product Portfolios and Specifications
13.5.3 New England Biolabs Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 New England Biolabs Main Business Overview
13.5.5 New England Biolabs Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Taq DNA Polymerase Product Portfolios and Specifications
13.6.3 Roche Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 Promega Corporation
13.7.1 Promega Corporation Company Information
13.7.2 Promega Corporation Taq DNA Polymerase Product Portfolios and Specifications
13.7.3 Promega Corporation Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Promega Corporation Main Business Overview
13.7.5 Promega Corporation Latest Developments
13.8 Agilent
13.8.1 Agilent Company Information
13.8.2 Agilent Taq DNA Polymerase Product Portfolios and Specifications
13.8.3 Agilent Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Agilent Main Business Overview
13.8.5 Agilent Latest Developments
13.9 Vazyme
13.9.1 Vazyme Company Information
13.9.2 Vazyme Taq DNA Polymerase Product Portfolios and Specifications
13.9.3 Vazyme Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Vazyme Main Business Overview
13.9.5 Vazyme Latest Developments
13.10 TransGen Biotech
13.10.1 TransGen Biotech Company Information
13.10.2 TransGen Biotech Taq DNA Polymerase Product Portfolios and Specifications
13.10.3 TransGen Biotech Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 TransGen Biotech Main Business Overview
13.10.5 TransGen Biotech Latest Developments
13.11 Yeasen
13.11.1 Yeasen Company Information
13.11.2 Yeasen Taq DNA Polymerase Product Portfolios and Specifications
13.11.3 Yeasen Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Yeasen Main Business Overview
13.11.5 Yeasen Latest Developments
13.12 Abclonal
13.12.1 Abclonal Company Information
13.12.2 Abclonal Taq DNA Polymerase Product Portfolios and Specifications
13.12.3 Abclonal Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Abclonal Main Business Overview
13.12.5 Abclonal Latest Developments
13.13 CWbio
13.13.1 CWbio Company Information
13.13.2 CWbio Taq DNA Polymerase Product Portfolios and Specifications
13.13.3 CWbio Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 CWbio Main Business Overview
13.13.5 CWbio Latest Developments
13.14 Novoprotein
13.14.1 Novoprotein Company Information
13.14.2 Novoprotein Taq DNA Polymerase Product Portfolios and Specifications
13.14.3 Novoprotein Taq DNA Polymerase Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Novoprotein Main Business Overview
13.14.5 Novoprotein Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.